DSIP 20mg — Vial Spec, Reconstitution Math & COA

DSIP 20mg Vial Specification & Format Overview

Delta-Sleep-Inducing Peptide (DSIP) is an endogenous nonapeptide with the primary amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (molecular weight approximately 848.81 g/mol). In a 20mg vial configuration, the peptide is presented as a lyophilized, sterile, vacuum-sealed cake designed for rapid dissolution in standard laboratory diluents. This higher-mass packaging size is primarily selected by research facilities conducting multi-cohort animal trials, continuous infusion experiments via micro-osmotic pumps, or high-throughput baseline receptor binding assays.

While PX1 Research maintains high-volume manufacturing capabilities for bulk laboratory orders across all peptides, our standard catalog currently features the highly requested DSIP 5mg vial size to minimize waste during short-duration trials. However, understanding the physical chemistry, reconstitution dynamics, and concentration math of the 20mg format remains essential for investigators scaling up experimental designs or evaluating custom synthesis requests for high-capacity projects.

Molecular Mechanism & Preclinical Research Focus

Preclinical studies indicate that DSIP readily crosses the blood-brain barrier through saturated transport mechanisms to exert regulatory influence over central neurochemical architecture. In animal models, central administration of DSIP has been demonstrated to promote electroencephalographic (EEG) slow-wave activity, specifically augmenting delta-wave frequencies (0.5–4.0 Hz) characteristic of deep non-REM sleep phases without disrupting overall circadian rhythm patterns.

Beyond electrophysiological modulation, in vitro data and preclinical research suggest that DSIP interacts directly with the hypothalamic-pituitary-adrenal (HPA) axis. In rodent stress models, DSIP administration attenuated hyper-secretion of adrenocorticotropic hormone (ACTH) and corticosterone, while stabilizing luteinizing hormone (LH) pulsatility. Investigators exploring neuroendocrine adaptation, stress resilience, and restorative physiological mechanisms frequently examine DSIP alongside related regulatory nonapeptides and neuropeptides documented within our comprehensive research library.

Volumetric Reconstitution Calculations for 20mg Mass

Accurate volumetric preparation is critical when handling a 20mg lyophilized cake to prevent concentration errors in experimental dosing. Because a 20mg yield contains four times the active peptide mass of a standard 5mg vial, researchers must adjust diluent volumes to achieve target working concentrations. To prevent rapid saturation or excessive viscosity, Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline (0.9% NaCl) should be introduced slowly along the glass wall of the vial.

Standard laboratory reconstitution matrices for a 20mg DSIP vial include the following concentration ratios: - 1.0 mL Diluent = 20.0 mg/mL concentration (20.0 µg per microliter) - 2.0 mL Diluent = 10.0 mg/mL concentration (10.0 µg per microliter) - 3.0 mL Diluent = 6.67 mg/mL concentration (6.67 µg per microliter) - 4.0 mL Diluent = 5.0 mg/mL concentration (5.0 µg per microliter) - 5.0 mL Diluent = 4.0 mg/mL concentration (4.0 µg per microliter)

For precise automated liquid handling or micro-pipetting, laboratory technicians should utilize our interactive reconstitution calculator to compute exact diluent requirements based on customized target concentrations and syringe unit calibrations.

Aliquot Planning and Laboratory Storage Protocols

To maintain structural integrity and biological activity, lyophilized DSIP 20mg vials must be stored in a freezer maintained at -20°C to -80°C, isolated from light and moisture. Unopened lyophilized vials stored under sub-zero conditions exhibit stability profiles exceeding 24 months. Prior to reconstitution, vials should be allowed to equilibrate to ambient room temperature to prevent condensation formation inside the container.

Once reconstituted with bacteriostatic diluents, the solution remains chemically stable at 2°C to 8°C for up to 28 days. However, because repeated freeze-thaw cycles cause peptide bond cleavage and irreversible mechanical degradation, high-volume reconstituted solutions (such as those derived from 20mg cakes) should be subdivided immediately into single-use micro-aliquots using sterile polyallomer or polypropylene tubes. These aliquots can be snap-frozen at -80°C for extended experimental protocols.

Analytical Verification and Lot-Matched COA Standards

PX1 Research enforces strict quality control metrics for every peptide batch produced in our GMP-compliant, USA-based manufacturing facilities. Each lot undergoes comprehensive analytical verification by an independent ISO 17025 accredited laboratory, ensuring uncompromising structural accuracy and chemical purity.

Every batch of DSIP undergoes High-Performance Liquid Chromatography (HPLC) to confirm peptide purity levels consistently meeting or exceeding 99%. Additionally, Mass Spectrometry (MS) analysis is conducted to confirm the exact molecular mass (848.81 Da) and sequence integrity. Endotoxin testing via Limulus Amebocyte Lysate (LAL) assay guarantees endotoxin thresholds fall strictly below <0.05 EU/mg, protecting sensitive cell cultures and animal models from confounding inflammatory responses.

Comparative Analysis: DSIP vs. Sleep & Recovery Research Compounds

When designing preclinical protocols investigating sleep architecture, stress modulation, or tissue recovery, principal investigators often evaluate DSIP alongside other peptide compounds that operate on distinct biochemical pathways. Selecting the appropriate agent depends on whether the protocol targets delta-wave sleep induction, systemic peptide signaling, or pituitary growth factor secretion.

For instance, while DSIP modulates central EEG delta-wave power and HPA-axis stress response, compounds like Epithalon influence pineal gland activity and telomerase gene expression to regulate circadian patterns. Similarly, growth hormone secretagogues such as GHRP-2 alter physiological recovery dynamics by stimulating pituitary somatotrophs rather than direct central sleep centers. Comparing these mechanisms in controlled rodent models provides insights into multi-system restorative pathways.

Selecting the Optimal Vial Size: 5mg vs. 20mg

Deciding between a 5mg and a 20mg DSIP vial depends primarily on protocol length, subject count, and liquid handling constraints. A 20mg vial is optimal for large-scale animal studies involving daily dosing across multiple research cohorts, or for continuous micro-infusion setups where high-concentration stock solutions are required. The 20mg format minimizes vial changes and reduces per-milligram raw material expenditures.

Conversely, smaller formats like our standard DSIP 5mg vial are better suited for pilot studies, acute single-dose trials, or assays with intermittent testing schedules. Utilizing 5mg vials reduces the duration that reconstituted solutions remain in liquid storage, thereby mitigating the risk of inadvertent peptide degradation or bacterial contamination during extended experiments.

Institutional Procurement & Custom Lab Services

PX1 Research supports university laboratories, biotechnology organizations, and institutional procurement departments requiring consistent batch-to-batch reproducibility. Orders placed before 3:00 PM EST ship same-day from our dual distribution hubs in California and Arizona, packaged with insulated thermal barriers to preserve peptide stability during transit.

For high-volume laboratories requiring bulk unit allocations, custom fill volumes (including specialized 20mg or 50mg vial formats), or dedicated lot reservation, institutional researchers can submit request details directly through our wholesale account portal. All procurement accounts receive complete access to downloadable, lot-matched COAs and direct technical support from our analytical team.